Kazia Therapeutics Income Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	2015 - 2019
Operating Revenue	2.31	-	-	15.18	-	Upgrade
Other Revenue	0.17	0	0.01	-	0.99	Upgrade
Revenue	2.48	0	0.01	15.18	0.99	Upgrade
Revenue Growth (YoY)	248000.00%	-90.00%	-99.93%	1436.54%	-31.38%	Upgrade
Gross Profit	2.48	0	0.01	15.18	0.99	Upgrade
Selling, General & Admin	13.56	8.58	5.24	7.02	3.69	Upgrade
Research & Development	17.38	15.56	20.17	14.54	9.49	Upgrade
Other Operating Expenses	-	-	-0.02	-0	-0	Upgrade
Operating Expenses	30.94	24.15	25.39	21.56	13.18	Upgrade
Operating Income	-28.46	-24.15	-25.38	-6.38	-12.19	Upgrade
Interest & Investment Income	0.01	0.02	0	0.04	0.07	Upgrade
Currency Exchange Gain (Loss)	-	-	-	-	0	Upgrade
Other Non Operating Income (Expenses)	1.28	-	-	-	-	Upgrade
EBT Excluding Unusual Items	-27.17	-24.12	-25.38	-6.34	-12.12	Upgrade
Gain (Loss) on Sale of Investments	-	-	-	-	-0.17	Upgrade
Other Unusual Items	0.12	3.39	-	-2.57	-0.47	Upgrade
Pretax Income	-27.05	-20.74	-25.38	-8.91	-12.77	Upgrade
Income Tax Expense	-0.27	-0.27	-0.37	-0.48	-0.3	Upgrade
Earnings From Continuing Operations	-26.78	-20.47	-25.01	-8.42	-12.47	Upgrade
Net Income	-26.78	-20.47	-25.01	-8.42	-12.47	Upgrade
Net Income to Common	-26.78	-20.47	-25.01	-8.42	-12.47	Upgrade
Shares Outstanding (Basic)	1	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	1	0	0	0	0	Upgrade
Shares Change (YoY)	43.08%	39.12%	12.57%	61.08%	27.04%	Upgrade
EPS (Basic)	-50.78	-55.53	-94.42	-35.78	-85.33	Upgrade
EPS (Diluted)	-50.78	-55.53	-94.42	-35.80	-85.35	Upgrade
Free Cash Flow	-9.58	-15.16	-22.76	-9.11	-8.81	Upgrade
Free Cash Flow Per Share	-18.17	-41.12	-85.92	-38.71	-60.30	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-1147.20%	-2414600.00%	-253840.00%	-42.01%	-1234.06%	Upgrade
Profit Margin	-1079.32%	-2046500.00%	-250140.00%	-55.47%	-1261.75%	Upgrade
Free Cash Flow Margin	-386.17%	-1515600.00%	-227620.00%	-60.01%	-891.55%	Upgrade
EBITDA	-26.59	-22.28	-23.52	-5.11	-11.11	Upgrade
EBITDA Margin	-	-	-	-33.68%	-	Upgrade
D&A For EBITDA	1.87	1.87	1.87	1.27	1.08	Upgrade
EBIT	-28.46	-24.15	-25.38	-6.38	-12.19	Upgrade
EBIT Margin	-	-	-	-42.01%	-	Upgrade

Updated Nov 15, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q